TipRanks
Newron Pharmaceuticals SpA (DE:NP5)
XETRA:NP5
Germany Market
NP5
Newron Pharmaceuticals SpA
RESEARCH TOOLSreports

Newron Pharmaceuticals SpA (NP5) Stock News & Sentiment

3 Followers
Newron Faces Ongoing FDA Hold on U.S. Arm of Key Evenamide Schizophrenia Trial
Premium
Company Announcements
Newron Faces Ongoing FDA Hold on U.S. Arm of Key Evenamide Schizophrenia Trial
12d ago
Newron Bolsters Finances as Evenamide Phase 3 Program Advances Toward 2027 Readouts
Premium
Company Announcements
Newron Bolsters Finances as Evenamide Phase 3 Program Advances Toward 2027 Readouts
16d ago
Newron Ramps Up Evenamide Phase 3 as Financing and Patent Wins Offset Wider Loss
Premium
Company Announcements
Newron Ramps Up Evenamide Phase 3 as Financing and Patent Wins Offset Wider Loss
16d ago
Newron secures EUR 5.5 million tranche to fund Phase 3 Evenamide program
Premium
Company Announcements
Newron secures EUR 5.5 million tranche to fund Phase 3 Evenamide program
30d ago
Newron Bolsters Phase 3 Schizophrenia Program with EUR 5.5 Million Share Subscription
Premium
Company Announcements
Newron Bolsters Phase 3 Schizophrenia Program with EUR 5.5 Million Share Subscription
30d ago
Newron completes pivotal Phase 3 recruitment for Evenamide in treatment-resistant schizophrenia
Premium
Company Announcements
Newron completes pivotal Phase 3 recruitment for Evenamide in treatment-resistant schizophrenia
1M ago
Newron Advances Pivotal Phase 3 Trial of Schizophrenia Candidate Evenamide
Premium
Company Announcements
Newron Advances Pivotal Phase 3 Trial of Schizophrenia Candidate Evenamide
1M ago
More DE:NP5 News >

NP5 News on the Web

Analysts Conflicted on These Healthcare Names: CSL (OtherCMXHF) and Newron Pharmaceuticals SpA (OtherNWPHF)
TipRanks News
Bullish
Newron Pharma price target lowered to CHF 19 from CHF 35 at Roth Capital
TipRanks News
Neutral
Newron Faces Ongoing FDA Hold on U.S. Arm of Key Evenamide Schizophrenia Trial
TipRanks News
Neutral
Newron secures EUR 5.5 million tranche to fund Phase 3 Evenamide program
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Regeneron (REGN), Newron Pharmaceuticals SpA (OtherNWPHF) and Boston Scientific (BSX)
TipRanks News
Bullish
Newron, FDA in constructive talks over U.S. trial halt for schizophrenia drug Evenamide
TipRanks News
Neutral
H.C. Wainwright Sticks to Its Buy Rating for Newron Pharmaceuticals SpA (NWPHF)
TipRanks News
Bearish
Newron Pharmaceuticals’ Earnings Call Signals Pivotal Year Ahead
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
DE:NP5
Sector Average
Media Buzz
This Week2 articles
Weekly Average1.5 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:NP5’s Media Buzz Sentiment?
2 articles about DE:NP5 were published this week. In an average week, 1.5 articles are published.
    What is DE:NP5’s weekly average amount of articles?
    In an average week, 1.5 articles about DE:NP5 are published.
      What is DE:NP5’s News Sentiment?
      100% of articles about DE:NP5 were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        REGNRegeneron
        QTTBQ32 Bio
        NVSNovartis
        RHHVFRoche Holding AG
        KRROKorro Bio
        Showing the stocks with the most bullish news sentiment over the past week